Intein-mediated expression, purification, and characterization of thymosin α1-thymopentin fusion peptide in Escherichia coli

Protein Expression and Purification
Juan LiFengshan Wang

Abstract

Thymosin α1-thymopentin (Tα1-TP5) fusion peptide has been proved to be an immune regulator based on its higher immunoregulatory activity than Tα1 and TP5. To obtain Tα1-TP5 more effectively and economically, Tα1-TP5 was genetically fused to a self-cleaving intein-chitin binding domain tag for purification via chitin beads in Escherichia coli. After affinity purification, the target peptide was released from the chitin beads via self-cleaving intein ((INTervening protEIN) induced by dithiothreitol. Further, Tα1-TP5 was purified by Superdex 30 and identified by Tricine-SDS-PAGE and electrospray ionization-mass spectrometry. Finally, about 7.6 mg Tα1-TP5 purified from the soluble fraction and inclusion bodies was obtained from 1 L culture media. The purity was 95% after a series of chromatographic purification steps. In vitro, the purified Tα1-TP5 could stimulate the proliferation of mouse splenic lymphocytes. Overall, this work demonstrated that Tα1-TP5 was purified with low cost and high efficiency, greatly expanding its potential use as an immune regulator.

References

May 1, 1994·Trends in Biotechnology·P A NygrenM Uhlén
Jul 18, 1997·Journal of Medicinal Chemistry·J I DeGrawI Uchida
Mar 13, 1998·Biotechnology Progress·E De Bernardez ClarkJ Maachupalli-Reddy
Jun 25, 1998·Immunologic Research·V K SinghS S Agarwal
Jun 5, 2001·Protein Expression and Purification·E J Cantor, S Chong
Jun 27, 2003·Biotechnology and Bioengineering·A Mark Buswell, Anton P J Middelberg
Nov 14, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yashu YinHaiyang Hu
Feb 17, 2007·Biotechnology and Bioengineering·Gareth J MannallPaul A Dalby
Sep 14, 2007·Journal of Pharmaceutical Sciences·Weiling HeZhi-Rong Zhang
Jul 1, 2008·Protein Expression and Purification·Federica VolontèGianluca Molla
Jul 23, 2008·Journal of Biomedicine & Biotechnology·Liang ZhouYi Xie
Nov 22, 2008·Archives of Pharmacal Research·Demin GaoFengshan Wang
Nov 10, 2009·International Journal of Pharmaceutics·Yan ZhangSuming Li
Jun 1, 2011·PloS One·Chandrasekhar NatarajanJay F Storz
Jun 3, 2011·Microbial Cell Factories·Lei XingZhanglin Lin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.